Resources

This document guides aged care providers on how to provide Monthly Care Statements to their residents.

This dashboard provides a snapshot of bulk billing for GP non referred attendances (GP NRA) and Medicare Bulk Billing Practices (those registered for the Bulk Billing Practice Incentive Program) for the January to March 2026 reporting quarter.

This is the Australian Governments response to the Joint Standing Committees recommendations on the National Disability Insurance Scheme Report.

Appliance Scheme product utilisation data quarterly report for January to March 2026.

The Hospital Casemix Protocol (HCP) data specification for General Treatment-Dental files for 2026–27 details the financial, clinical and demographic data that hospitals must provide private health insurers. Private health insurers must then provide this data to us. Effective from 1 July 2026.

The Hospital Casemix Protocol (HCP) data specification for HCP1 files for 2026–27 details the financial, clinical and demographic data that hospitals must provide private health insurers. Private health insurers must then provide this data to us. Effective from 1 July 2026.

The Hospital Casemix Protocol (HCP) data specification for HCP2 files for 2026–27 details the financial, clinical and demographic data that hospitals must provide private health insurers. Private health insurers must then provide this data to us. Effective from 1 July 2026.

The Hospital Casemix Protocol (HCP) data specifications for HCP files details the financial, clinical and demographic data that hospitals must provide to private health insurers. Private health insurers must then provide this data to us. Effective from 1 July 2026.

The Private Health Data Bureau (PHDB) data specifications for 2024–25 details the financial, clinical and demographic data that hospitals must provide to us. Effective from 1 July 2026.

Information about premature, early and medically induced menopause.

his public interest certificate (PIC) relates to the following tender: Procurement of National Blood Stem Cell Donation Services.

The draft departmental report summarises the review process and outcomes. Stakeholders can provide feedback on the proposed recommendations.

This report outlines the research we undertook to help develop our campaign.

This certification statement, signed by Secretary Blair Comley on 14 May 2026, certifies that the National Menopause and Perimenopause Awareness campaign complies with relevant guidelines and policies.

A practical guide to understanding perimenopause and menopause, providing an overview of this life stage, common symptoms, and the management and support options available.

Learn about the different ways to manage menopause-related symptoms, including lifestyle changes, treatment options and where to seek support. 

The ‘menopause transition’ includes perimenopause and menopause.  During the menopause transition the levels of oestrogen and progesterone, hormones produced by the ovaries, change. This causes menopause-related symptoms.   People might also describe these symptoms as ‘perimenopause symptoms’.

Partners, family and friends play an important role in supporting their loved one through the menopause transition.  

Everyone experiences perimenopause differently. Perimenopause usually starts in your 40s, but it can be earlier.

Many women experience symptoms for a number of years before reaching menopause.